LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that it met the primary endpoints for its OSPREY randomized controlled trial (RCT), Treating Obstructive Sleep ...
Deep Brain Stimulation (DBS) involves implanting electrodes in specific areas of the brain that deliver electrical pulses to help regulate abnormal brain activity. This can alleviate symptoms such as ...
Nexalin's next-generation devices, including the Gen-2 15 milliamp neurostimulation device, have been approved in various international markets such as China, Brazil, and Oman. The company's ...
As One UI 6.1.1 continues to roll out, Samsung’s October 2024 update may or may not bring that update to your device. The main focus of these monthly updates is always on security, and October ...